Key Details
Price
$21.20Last Dividend
$0.17PE Ratio
58.89Annual ROE
-10.01%Beta
1.39Events Calendar
Next earnings date:
Feb 07, 2025Recent quarterly earnings:
Nov 06, 2024Recent annual earnings:
Feb 07, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 12, 2024Next split:
N/ARecent split:
Feb 11, 2010Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
SANTA MONICA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) (the “Company” or “Macerich”) announced today that it has priced an underwritten public offering of 20,000,000 shares of common stock at a price to public of $19.75 per share for expected gross proceeds of approximately $395.0 million. The Company has also granted the underwriters a 30-day option to purchase up to 3,000,000 additional shares of its common stock. This reflects an upsizing of the previously announced offering of 18,000,000 shares of common stock. Subject to customary closing conditions, the offering is expected to close on November 27, 2024.
SANTA MONICA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) (the “Company” or “Macerich”) announced today that it has commenced an underwritten public offering of 18,000,000 shares of common stock. The Company expects to grant the underwriters a 30-day option to purchase up to 2,700,000 additional shares of its common stock.
MAC's Q3 performance reflects a year-over-year increase in interest expenses. However, same-center NOI, including lease termination income, rises.
The headline numbers for Macerich (MAC) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Macerich (MAC) came out with quarterly funds from operations (FFO) of $0.38 per share, missing the Zacks Consensus Estimate of $0.40 per share. This compares to FFO of $0.44 per share a year ago.
Dan Swanstrom Named as Chief Financial Officer of The Macerich Company Dan Swanstrom Named as Chief Financial Officer of The Macerich Company
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Macerich (MAC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.
The pricing announcement from the Center for Medicare Services became effective on October 1, 2024, and allows BioStem to begin marketing initiatives with Venture Medical POMPANO BEACH, Fla., October 29, 2024 – PRISM MediaWire – BioStem Technologies Inc.
5.37% Fixed Rate for 5 Years, Interest Only, on $525M Loan Lowest Refi Rate Achieved by Company in Past 5 Years SANTA MONICA, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: MAC), one of the nation's leading owners, operators and developers of major retail properties in top markets, today announced that it has refinanced fortress property Queens Center at highly favorable terms with a new $525 million loan bearing fixed interest of 5.37% and interest-only payments during the entire term.
Macerich is a REIT focused on malls and shopping centers, currently yielding 3.8%, with no clear growth story. Management aims to reduce debt by $2B through asset sales, but this likely means revenue and cash flows will decline in the near term. E-commerce growth and the shift from brick-and-mortar retail present significant challenges, making MAC's turnaround and profitable growth uncertain.
FAQ
- What is the primary business of Macerich?
- What is the ticker symbol for Macerich?
- Does Macerich pay dividends?
- What sector is Macerich in?
- What industry is Macerich in?
- What country is Macerich based in?
- When did Macerich go public?
- Is Macerich in the S&P 500?
- Is Macerich in the NASDAQ 100?
- Is Macerich in the Dow Jones?
- When was Macerich's last earnings report?
- When does Macerich report earnings?
- Should I buy Macerich stock now?